Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory condition that affects the lining of the large intestine and rectum. As a form of inflammatory bowel disease (IBD), UC is often associated with persistent inflammation, ulcer formation, and periods of flare-ups that can significantly impact daily life. Because oxygen plays a key role in tissue repair and inflammatory regulation, researchers have begun exploring Mild Hyperbaric Oxygen Therapy (mHBOT) as a potential supportive approach alongside standard medical care.
While research is still emerging, interest continues to grow around how increased oxygen availability may influence gut health and inflammatory processes.
What Is Mild Hyperbaric Oxygen Therapy?
Mild Hyperbaric Oxygen Therapy involves breathing oxygen in a pressurized environment that is slightly above normal atmospheric pressure, typically ranging from 1.3 to 1.5 ATA. Under these conditions, oxygen dissolves more efficiently into the blood plasma and body fluids, allowing it to reach tissues that may be compromised by inflammation or reduced circulation.
This increase in oxygen availability is believed to support cellular repair, immune modulation, and tissue healing throughout the body, including the gastrointestinal tract.
How mHBOT Is Being Studied in Relation to Ulcerative Colitis
Supporting Inflammatory Balance in the Gut
Chronic inflammation is a hallmark of ulcerative colitis. Several studies have examined hyperbaric oxygen therapy for its potential role in modulating inflammatory responses. By improving oxygen delivery to inflamed tissues, mHBOT may help create conditions that support a more balanced inflammatory environment within the colon.
Promoting Tissue Repair and Ulcer Healing
Ulcerative colitis often involves damage to the intestinal lining. Oxygen is essential for cellular repair and regeneration, and hyperbaric oxygen exposure has been studied for its role in supporting wound healing processes. These mechanisms are of particular interest when considering tissue recovery in the digestive tract.
Comfort and Symptom Support
As inflammation decreases and tissue repair improves, some researchers have explored whether hyperbaric oxygen therapy may indirectly support symptom relief related to discomfort. While individual experiences vary, this remains an area of continued investigation.
Reducing Risk Factors Associated With Chronic Inflammation
Long-term inflammation in UC can contribute to secondary complications. By supporting tissue oxygenation and healing pathways, mHBOT is being studied for its potential role as a complementary wellness tool when managing chronic inflammatory conditions.
Important Considerations
Mild Hyperbaric Oxygen Therapy is not intended to replace medical treatment for ulcerative colitis. Individuals with UC should always work closely with their gastroenterologist or healthcare provider when considering any complementary therapy. mHBOT is generally explored as an adjunct to conventional care rather than a standalone approach.
Looking Ahead
As research continues, Mild Hyperbaric Oxygen Therapy remains an area of interest for individuals seeking supportive wellness strategies alongside traditional ulcerative colitis management. While more large-scale studies are needed, current research suggests that oxygen-based therapies may play a role in supporting gut health, tissue repair, and inflammatory balance.
References
Harch PG, Andrews SR, Fogarty EF, et al. A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. Journal of Neurotrauma. 2012;29:168–185.
Dulai PS, Gleeson MW, Taylor D, et al. Safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease: A systematic review. Alimentary Pharmacology & Therapeutics. 2014;39(11):1266–1275.
Thom SR. Hyperbaric oxygen: Its mechanisms and efficacy. Plastic and Reconstructive Surgery. 2009;127(Suppl 1):131S–141S.
Guo S, Dipietro LA. Factors affecting wound healing. Journal of Dental Research. 2010;89(3):219–229.
Ghattas Khoury R, Abboud BN, Afram G. Role of hyperbaric oxygen therapy in inflammatory bowel disease. Journal of Medicinal Food. 2016;19(3):201–210.